Obese Hypertension Study (0954-315)

PHASE3CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

March 31, 2007

Conditions
Hypertension
Interventions
DRUG

Comparator: losartan +/- HCTZ

Placebo to losartan once daily for 4 weeks in run-in period. Then, losartan 50 mg for 4 weeks, then titrate to losartan 100 mg at Week 4, then titrate to losartan 100 mg + hydrochlorothiazide (HCTZ) 12.5 mg at Week 8, and finally titrate to losartan 100 mg + HCTZ 25 mg at Week 12. Duration of treatment is approximately 16 weeks.

DRUG

Comparator: Placebo

Placebo to losartan once daily for 4 weeks in run-in period. Then, placebo to losartan or losartan/HCTZ once daily for approximately 16 weeks.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00289887 - Obese Hypertension Study (0954-315) | Biotech Hunter | Biotech Hunter